Fever-tree Achieves Growth in the UK During Hot Summer Period

Fever-tree, known for its tonic and soft drinks, reported significant progress in the first half of 2026. With a favorable start to the summer, the company saw revenues rise by 8% to £183.6 million for the first six months ending June 30, 2026. This growth was consistent across different regions.

In the UK market, Fever-tree managed to turn around its growth trajectory with sales increasing by 3% to £49.5 million. One of the factors contributing to this was the robust performance in the off-trade sector.

Expansion was more rapid in the United States, where the company's revenues jumped by 11% at constant currency, reaching £66.9 million. This success in the US is largely credited to their partnership with Molson Coors, which has significantly increased Fever-tree's market share, particularly in the ginger beer and tonic categories.

Alongside rising sales, Fever-tree's profits also saw an improvement, with its EBITDA increasing by 9% to £20.1 million during the period.

CEO and co-founder Tim Warrillow highlighted the ongoing momentum in the US market as a result of their collaboration with Molson Coors, along with the positive reception of their national marketing campaign. In the UK, a new marketing strategy, “Straight up or Mixed,” capitalized on the summer weather and consumer preferences.

Tim Warrillow expressed confidence in meeting the full year's market expectations citing that Fever-tree's ongoing diversification strategy and cash-generative business model position the company well for future investments and shareholder returns.